ARTICLE | Company News
Remedyne, Bayer CEA licensing deal
March 4, 2002 8:00 AM UTC
Bayer (BAY; FSE:BAYG) granted Remedyne (Santa Barbara, Calif.) a non-exclusive license to its carcinoembryonic antigen (CEA) gene, for use in Remedyne's RemeStim-CEA cancer immunotherapeutic for U.S. ...